SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 64.02 |
| Enterprise Value ($M) | -71.69 |
| Book Value ($M) | 92.08 |
| Book Value / Share | 1.22 |
| Price / Book | 0.70 |
| NCAV ($M) | 81.64 |
| NCAV / Share | 1.08 |
| Price / NCAV | 0.78 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.67 |
| Return on Assets (ROA) | -0.72 |
| Return on Equity (ROE) | -1.03 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 5.90 |
| Current Ratio | 5.90 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 141.08 |
| Assets | 151.53 |
| Liabilities | 59.45 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 15.53 |
| Operating Income | -88.13 |
| Net Income | -87.68 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -79.00 |
| Cash from Investing | 44.98 |
| Cash from Financing | 88.33 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Alyeska Investment Group, L.P. | 9.99 | ||
| 13G | Armistice Capital, Llc | 9.99 | ||
| 13G/A | Tang Capital Partners Lp | 3.00 | -22.25 | |
| 13G/A | Baker Bros. Advisors Lp | 4.99 | 76.46 | |
| 13G/A | Hillhouse Capital Advisors, Ltd. | 8.20 | 158.53 | |
| 13G/A | EcoR1 Capital, LLC | 9.99 | 83.98 | |
| 13D/A | Versant Venture Capital VI, L.P. | 1.90 | 0.00 | |
| 13G/A | Roche Finance Ltd | 15.35 | 256.56 | |
| 13D | Blatt Lawrence | 5.30 | 45.19 | |
| 13G | Deep Track Capital, LP | 9.99 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 53,952 | 182,528 | 29.56 | |
| 45,920 | 38,169 | 120.31 | |
| 16,808 | 22,766 | 73.83 | |
| 33,690 | 36,683 | 91.84 | |
| 17,945 | 22,469 | 79.87 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| AKBA – Akebia Therapeutics, Inc. | ALBT – Avalon GloboCare Corp. |
| ALDX – Aldeyra Therapeutics, Inc. | ALRN – Aileron Therapeutics, Inc. |
| ALZN – Alzamend Neuro, Inc. |
Financial data and stock pages provided by
Fintel.io